Phillips SF - Search Results

1

Selective 5-hydroxytryptamine type 3 receptor antagonism with ondansetron as treatment for diarrhea-predominant irritable bowel syndrome: a pilot study.

Steadman CJ, Talley NJ, Phillips SF, Zinsmeister AR. Steadman CJ, et al. Among authors: phillips sf. Mayo Clin Proc. 1992 Aug;67(8):732-8. doi: 10.1016/s0025-6196(12)60797-6. Mayo Clin Proc. 1992. PMID: 1434911 Clinical Trial.

2

Effects of an irritable bowel syndrome educational class on health-promoting behaviors and symptoms.

Colwell LJ, Prather CM, Phillips SF, Zinsmeister AR. Colwell LJ, et al. Among authors: phillips sf. Am J Gastroenterol. 1998 Jun;93(6):901-5. doi: 10.1111/j.1572-0241.1998.00273.x. Am J Gastroenterol. 1998. PMID: 9647015

3

Relation among personality and symptoms in nonulcer dyspepsia and the irritable bowel syndrome.

Talley NJ, Phillips SF, Bruce B, Twomey CK, Zinsmeister AR, Melton LJ 3rd. Talley NJ, et al. Among authors: phillips sf. Gastroenterology. 1990 Aug;99(2):327-33. doi: 10.1016/0016-5085(90)91012-u. Gastroenterology. 1990. PMID: 2365186

4

Effect of selective 5HT3 antagonist (GR 38032F) on small intestinal transit and release of gastrointestinal peptides.

Talley NJ, Phillips SF, Haddad A, Miller LJ, Twomey C, Zinsmeister AR, Ciociola A. Talley NJ, et al. Among authors: phillips sf. Dig Dis Sci. 1989 Oct;34(10):1511-5. doi: 10.1007/BF01537102. Dig Dis Sci. 1989. PMID: 2529108 Clinical Trial.

5

A patient questionnaire to identify bowel disease.

Talley NJ, Phillips SF, Melton J 3rd, Wiltgen C, Zinsmeister AR. Talley NJ, et al. Among authors: phillips sf. Ann Intern Med. 1989 Oct 15;111(8):671-4. doi: 10.7326/0003-4819-111-8-671. Ann Intern Med. 1989. PMID: 2679285

6

Dysmotility of the small intestine in irritable bowel syndrome.

Kellow JE, Phillips SF, Miller LJ, Zinsmeister AR. Kellow JE, et al. Among authors: phillips sf. Gut. 1988 Sep;29(9):1236-43. doi: 10.1136/gut.29.9.1236. Gut. 1988. PMID: 3197998 Free PMC article.

7

Campylobacter pylori and Barrett's esophagus.

Talley NJ, Cameron AJ, Shorter RG, Zinsmeister AR, Phillips SF. Talley NJ, et al. Among authors: phillips sf. Mayo Clin Proc. 1988 Dec;63(12):1176-80. doi: 10.1016/s0025-6196(12)65402-0. Mayo Clin Proc. 1988. PMID: 3199885

8

Altered sensitivity of the gallbladder to cholecystokinin octapeptide in irritable bowel syndrome.

Kellow JE, Miller LJ, Phillips SF, Zinsmeister AR, Charboneau JW. Kellow JE, et al. Among authors: phillips sf. Am J Physiol. 1987 Nov;253(5 Pt 1):G650-5. doi: 10.1152/ajpgi.1987.253.5.G650. Am J Physiol. 1987. PMID: 3318495

9

Visceral perception in irritable bowel syndrome. Rectal and gastric responses to distension and serotonin type 3 antagonism.

Zighelboim J, Talley NJ, Phillips SF, Harmsen WS, Zinsmeister AR. Zighelboim J, et al. Among authors: phillips sf. Dig Dis Sci. 1995 Apr;40(4):819-27. doi: 10.1007/BF02064986. Dig Dis Sci. 1995. PMID: 7720476 Clinical Trial.

10

Effect of a 5HT3-antagonist (ondansetron) on rectal sensitivity and compliance in health and the irritable bowel syndrome.

Hammer J, Phillips SF, Talley NJ, Camilleri M. Hammer J, et al. Among authors: phillips sf. Aliment Pharmacol Ther. 1993 Oct;7(5):543-51. doi: 10.1111/j.1365-2036.1993.tb00131.x. Aliment Pharmacol Ther. 1993. PMID: 8280823 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

282 results

Search Page

Filters